Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites

Abstract Metabolomics has been attracting attention in recent years as an objective method for diagnosing schizophrenia. In this study, we analyzed 378 metabolites in the serum of schizophrenia patients using capillary electrophoresis‐ and liquid chromatography‐time‐of‐flight mass spectrometry. Usin...

Full description

Bibliographic Details
Main Authors: Saehyeon Kim, Satoshi Okazaki, Ikuo Otsuka, Yutaka Shinko, Tadasu Horai, Naofumi Shimmyo, Takashi Hirata, Naruhisa Yamaki, Takaki Tanifuji, Shuken Boku, Ichiro Sora, Akitoyo Hishimoto
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Neuropsychopharmacology Reports
Subjects:
Online Access:https://doi.org/10.1002/npr2.12223
_version_ 1811178000472866816
author Saehyeon Kim
Satoshi Okazaki
Ikuo Otsuka
Yutaka Shinko
Tadasu Horai
Naofumi Shimmyo
Takashi Hirata
Naruhisa Yamaki
Takaki Tanifuji
Shuken Boku
Ichiro Sora
Akitoyo Hishimoto
author_facet Saehyeon Kim
Satoshi Okazaki
Ikuo Otsuka
Yutaka Shinko
Tadasu Horai
Naofumi Shimmyo
Takashi Hirata
Naruhisa Yamaki
Takaki Tanifuji
Shuken Boku
Ichiro Sora
Akitoyo Hishimoto
author_sort Saehyeon Kim
collection DOAJ
description Abstract Metabolomics has been attracting attention in recent years as an objective method for diagnosing schizophrenia. In this study, we analyzed 378 metabolites in the serum of schizophrenia patients using capillary electrophoresis‐ and liquid chromatography‐time‐of‐flight mass spectrometry. Using multivariate analysis with the orthogonal partial least squares method, we observed significantly higher levels of alanine, glutamate, lactic acid, ornithine, and serine and significantly lower levels of urea, in patients with chronic schizophrenia compared to healthy controls. Additionally, levels of fatty acids (15:0), (17:0), and (19:1), cis‐11‐eicosenoic acid, and thyroxine were significantly higher in patients with acute psychosis than in those in remission. Moreover, we conducted a systematic review of comprehensive metabolomics studies on schizophrenia over the last 20 years and observed consistent trends of increase in some metabolites such as glutamate and glucose, and decrease in citrate in schizophrenia patients across several studies. Hence, we provide substantial evidence for metabolic biomarkers in schizophrenia patients through our metabolomics study.
first_indexed 2024-04-11T06:10:55Z
format Article
id doaj.art-77c7a8001d2148dd867de5ebda0a7fab
institution Directory Open Access Journal
issn 2574-173X
language English
last_indexed 2024-04-11T06:10:55Z
publishDate 2022-03-01
publisher Wiley
record_format Article
series Neuropsychopharmacology Reports
spelling doaj.art-77c7a8001d2148dd867de5ebda0a7fab2022-12-22T04:41:16ZengWileyNeuropsychopharmacology Reports2574-173X2022-03-01421425110.1002/npr2.12223Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolitesSaehyeon Kim0Satoshi Okazaki1Ikuo Otsuka2Yutaka Shinko3Tadasu Horai4Naofumi Shimmyo5Takashi Hirata6Naruhisa Yamaki7Takaki Tanifuji8Shuken Boku9Ichiro Sora10Akitoyo Hishimoto11Department of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanDepartment of Psychiatry Kobe University Graduate School of Medicine Kobe JapanAbstract Metabolomics has been attracting attention in recent years as an objective method for diagnosing schizophrenia. In this study, we analyzed 378 metabolites in the serum of schizophrenia patients using capillary electrophoresis‐ and liquid chromatography‐time‐of‐flight mass spectrometry. Using multivariate analysis with the orthogonal partial least squares method, we observed significantly higher levels of alanine, glutamate, lactic acid, ornithine, and serine and significantly lower levels of urea, in patients with chronic schizophrenia compared to healthy controls. Additionally, levels of fatty acids (15:0), (17:0), and (19:1), cis‐11‐eicosenoic acid, and thyroxine were significantly higher in patients with acute psychosis than in those in remission. Moreover, we conducted a systematic review of comprehensive metabolomics studies on schizophrenia over the last 20 years and observed consistent trends of increase in some metabolites such as glutamate and glucose, and decrease in citrate in schizophrenia patients across several studies. Hence, we provide substantial evidence for metabolic biomarkers in schizophrenia patients through our metabolomics study.https://doi.org/10.1002/npr2.12223biomarkersmetabolomicspsychosisschizophreniasystematic review
spellingShingle Saehyeon Kim
Satoshi Okazaki
Ikuo Otsuka
Yutaka Shinko
Tadasu Horai
Naofumi Shimmyo
Takashi Hirata
Naruhisa Yamaki
Takaki Tanifuji
Shuken Boku
Ichiro Sora
Akitoyo Hishimoto
Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
Neuropsychopharmacology Reports
biomarkers
metabolomics
psychosis
schizophrenia
systematic review
title Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
title_full Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
title_fullStr Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
title_full_unstemmed Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
title_short Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
title_sort searching for biomarkers in schizophrenia and psychosis case control study using capillary electrophoresis and liquid chromatography time of flight mass spectrometry and systematic review for biofluid metabolites
topic biomarkers
metabolomics
psychosis
schizophrenia
systematic review
url https://doi.org/10.1002/npr2.12223
work_keys_str_mv AT saehyeonkim searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT satoshiokazaki searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT ikuootsuka searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT yutakashinko searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT tadasuhorai searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT naofumishimmyo searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT takashihirata searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT naruhisayamaki searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT takakitanifuji searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT shukenboku searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT ichirosora searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites
AT akitoyohishimoto searchingforbiomarkersinschizophreniaandpsychosiscasecontrolstudyusingcapillaryelectrophoresisandliquidchromatographytimeofflightmassspectrometryandsystematicreviewforbiofluidmetabolites